1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

16 Sep 2025
Admin
News Article

ProofPilot Acquires Lokavant to Build Next-Gen Clinical Trial Platform

New York, NY — ProofPilot, a leading end-to-end clinical experience platform, announced the acquisition of Lokavant, the clinical trial intelligence company known for its predictive analytics. The move integrates trial execution and AI-powered intelligence, creating a first-of-its-kind platform to help sponsors and CROs design, manage, and optimize clinical trials with greater speed and reliability.

Why This Matters

Execution + Intelligence: ProofPilot’s trial management tools now combine with Lokavant’s predictive analytics engine.
Real-Time Foresight: Sponsors gain the ability to anticipate risks, forecast outcomes, and intervene before problems arise.
Patient-Centric Efficiency: Faster recruitment, better compliance, and improved site training—leading to shorter timelines and higher-quality data.

Inside the Integration

Predictive forecasting: AI-driven models (including generative AI and causal AI) predict enrollment timelines and operational risks.
Site training & oversight: Real-time adherence and data quality signals enable proactive interventions.
Recruitment optimization: Build and monitor campaigns with real-time dashboards.
Smarter scenario planning: Sponsors can run simulations to prepare for challenges before they occur.

Executive Perspectives

Chris Venezia, CEO, ProofPilot

“By bringing Lokavant’s predictive analytics engine into our platform, we’re giving customers an industry-first ability to measure and predict trial success in real time.”

Rohit Nambisan, CEO & Co-Founder, Lokavant

“Together, we give sponsors and CROs unprecedented clarity and foresight into study performance—setting a new standard for how trials are designed and executed.”

Alex Gasner, EVP Roivant Health

“This move aligns with Roivant’s mission—accelerating development of medicines that matter. Biopharma will now deliver innovative therapies faster and with greater impact.”

About the Companies

ProofPilot

Modernizes how trials are launched and managed.
Focus: simplify site operations, reduce patient burden, improve compliance.
End-to-end platform: recruitment → execution → closeout.

Lokavant

Spun out of Roivant (2020).
Specializes in AI-driven study forecasting via its flagship tool Spectrum.
Key impact:
- 70% reduction in non-conformance events
- 70x improvement in forecasting accuracy
- Significant cuts in timelines and costs

Industry Context

Clinical trials face 40% average delays in enrollment and frequent cost overruns.
AI and predictive analytics are emerging as essential tools to de-risk operations.

With this acquisition, ProofPilot positions itself against players like Medidata, Veeva, and Oracle, but with a unique execution + intelligence stack.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!